BioCentury-BayHelix East-West Summit 2023 (B) | BioCentury | 4 October 2023 | Online

Facing long-term capital shortages, biopharma companies are under intense pressure to find creative solutions to keep their innovations alive.

One answer? Pursue global development strategies.

Pressure test your globalization strategy at this Summit, where BioCentury, BayHelix and Insights Partner McKinsey & Company are
again bringing together a global community of C-level executives to debate:

• The best models for globalizing biotech value
• Why dealmaking between Asia and the West is accelerating despite geopolitical stress
• The evolution of the cross-border landscape, and how it can be used to expand:
• Product development
• Financial runway
• Market access

2023 Speakers

Christiana Bardon, M.d.
Co-managing Partner, Mpm Bioimpact

Joshua Berlin
Head of Business Development, Biocentury Inc.

Karen Bernstein, Ph.d.
Co-founder & Chairman, Biocentury Inc.

Simone Fishburn, Ph.d.
Vice President & Editor in Chief, Biocentury Inc.

David Flores
Co-founder, President & Ceo, Biocentury Inc.

Arjen Lemmen
Vice President, Corporate Development & Strategy, Argenx

John Lepore, M.d.
Senior Vice President and Head of Research, Glaxosmithkline

Ji Li, Ph.d.
Principal, Jl Biopharma Consulting

Yvonne Lu
Co-lead, Global Biopharma Practice, Russell Reynolds Associates

Lauren Martz
Executive Director of Biopharma Intelligence, Biocentury Inc.

Christopher Mortko
Head, Headquarters Search and Evaluation, Merck & Co.

Wendy Pan, Ph.d.
Partner, Goodwin Procter

Rajesh Parekh, Ph.d.
Senior Partner, Mckinsey & Company

Robert Plenge, M.d., Ph.d.
Chief Research Officer, Bristol Myers Squibb

Andrew Plump, M.d., Ph.d.
President of R&d, Takeda Pharmaceutical Co. Ltd.

Josh Smiley
President & Chief Operating Officer, Zai Lab

Jackson Tai
Director, Eli Lilly and Company

Yu Tang, M.d.
Executive Director, Clinical Trial Center, National Cancer Center/cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Benjamin Thorner
General Counsel & Chief Business Officer, Eikon Therapeutics

Karen Tkach Tuzman, Ph.d.
Director of Biopharma Intelligence, Biocentury Inc.

Chris Viehbacher
President & Ceo, Biogen

Marietta Wu, M.d., Ph.d.
Managing Director, Quan Capital

Shanshan Xu, M.d., Ph.d.
Vice President, External Innovations
Biontech Us Inc.

Eric Yeung
Vp & Head of Oncology and Rare Diseases Global Business Development, Takeda

Dan Zhang, M.d.
Chairman, Hillgene Biopharma

2023 Sponsors and Partner

SPONSORS:
• Goodwin
• Lyfe
• Nutter
• Panacea Venture
• QUAN
• Russel Reynolds
• Takeda

PARTNER:
• McKinsey & Company